By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
May 1, 2024/Policies & Bylaws
Board policy: The CEO is an officer of the Board and in that capacity is authorized to execute or to authorize their designee to execute, on behalf of the association, certain binding agreements and other acts.
Apr 9, 2020/News
CDC calls for consistent employer efforts to pre-screen, monitor, disinfect, and support the use of masks and other PPE.
Apr 1, 2023/Article
Props to the Ethics in Practice column and a conversation with winners of the APTA Minority Scholarship Award.
PTs are under increasing pressure to ensure compliance with coverage, payment, coding, documentation, and billing requirements.
May 24, 2015/Test & Measure
This is an objective test of a variety of gait and mobility functions such as running, hopping, stair navigation, backward walking in patients with traumatic brain injury (TBI).
Mar 24, 2020/News
APTA joins effort for stepped up NPE response by Congress; new template letter for telehealth; wound care considered "essential," and more.
Mar 1, 2020/Article
What are the federal expectations for providers when it comes to non-discrimination, disability access, and the rights of patients with limited English proficiency?
Jul 7, 2017/Podcast
Listen to a discussion interview held at NEXT 2017 in Boston with Jeanine Gunn, PT, DPT, APTA Board of Directors treasurer on ways that today’s PT and PTA students can step-up, get involved, and make their mark on our profession.
Jun 25, 2018/News
The following members were elected to APTA's Board of Directors and Nominating Committee at the 2018 House of Delegates in Orlando, Florida.
Nov 11, 2021/CPG
This "living" guideline covers identifying, assessing, and managing the long-term effects of COVID-19, frequently described as "long COVID." It makes recommendations about care in all health care settings for adults, children, and young people who have new or ongoing symptoms lasting four weeks or more